Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma

Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the most common solid tumors worldwide, characterized by clinical aggressiveness, resistance to conventional chemotherapy, and high lethality. Consequently, there is an urgent need to better delineate the molecular pathogenesis of HCC to develop new preventiv...

Full description

Bibliographic Details
Main Authors:	Li Che, Panagiotis Paliogiannis, Antonio Cigliano, Maria G. Pilo, Xin Chen, Diego F. Calvisi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-12-01
Series:	Frontiers in Oncology
Subjects:	hepatocellular carcinoma de novo lipogenesis FASN tumor metabolism precision medicine
Online Access:	https://www.frontiersin.org/article/10.3389/fonc.2019.01412/full

Similar Items

Corrigendum: Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma
by: Li Che, et al.
Published: (2022-04-01)

Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis
by: Jiaoyuan Jia, et al.
Published: (2020-11-01)

Fatty Acid Synthase Inhibitor Platensimycin Intervenes the Development of Nonalcoholic Fatty Liver Disease in a Mouse Model
by: Meng Su, et al.
Published: (2021-12-01)

Inhibition of Fatty Acid Synthase Upregulates Expression of CD36 to Sustain Proliferation of Colorectal Cancer Cells
by: James Drury, et al.
Published: (2020-07-01)

De novo lipogenesis is elicited dramatically in human hepatocellular carcinoma especially in hepatitis C virus‐induced hepatocellular carcinoma
by: Shaojian Li, et al.
Published: (2020-09-01)

PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma
by: Shi-Zhe Zhang, et al.
Published: (2021-03-01)

Fatty acid synthase as a potential new therapeutic target for cervical cancer
by: JÉSSICA NASCIMENTO, et al.
Published: (2022-05-01)

The Deubiquitinase USP13 Maintains Cancer Cell Stemness by Promoting FASN Stability in Small Cell Lung Cancer
by: Juhong Wang, et al.
Published: (2022-07-01)

Emerging Therapeutic Activity of <i>Davallia formosana</i> on Prostate Cancer Cells through Coordinated Blockade of Lipogenesis and Androgen Receptor Expression
by: Po-Fan Hsieh, et al.
Published: (2020-04-01)

<b>DHEA and non-alcoholic fat liver disease: increased gene expression of peroxisome proliferation-activated receptor γ (PPARγ) and fatty acid synthase (FAS)
by: Felipe Natali Almeida, et al.
Published: (2014-05-01)

Orotic acid-treated hepatocellular carcinoma cells resist steatosis by modification of fatty acid metabolism
by: Johanna Matilainen, et al.
Published: (2020-04-01)

Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer
by: Azhar Ali, et al.
Published: (2018-03-01)

Emerging role of Fatty acid synthase in tumor initiation: implications for cancer prevention
by: Maria J. Bueno, et al.
Published: (2020-03-01)

AZ12756122, a novel fatty acid synthase inhibitor, decreases resistance features in EGFR-TKI resistant EGFR-mutated NSCLC cell models
by: Emma Polonio-Alcalá, et al.
Published: (2022-12-01)

Diallyl Sulfide-Mediated Modulation of the Fatty Acid Synthase (FASN) Leads to Cancer Cell Death in BaP-Induced Lung Carcinogenesis in Swiss Mice
by: Khan A, et al.
Published: (2020-12-01)

Dr. Novel missense variant L46Q of fatty acid synthase gene and fatty acids content in Awassi sheep
by: Tahreer Mohammed Al-Thuwaini, et al.
Published: (2022-07-01)

Targeting De Novo Lipogenesis and Cholesterol Biosynthesis Simultaneously is a Novel Therapeutic Option for Hepatocellular Carcinoma
by: Liu Q, et al.
Published: (2021-01-01)

Accumulation of cholesterol, triglycerides and ceramides in hepatocellular carcinomas of diethylnitrosamine injected mice
by: Elisabeth M. Haberl, et al.
Published: (2021-10-01)

Dual-tracer positron emission tomography/computed tomography as an imaging probe of de novo lipogenesis in preclinical models of hepatocellular carcinoma
by: Chin-Ho Tsao, et al.
Published: (2022-09-01)

Interaction of sodium acetate supplementation and dietary fiber level on feeding behavior, digestibility, milk synthesis, and plasma metabolites
by: C. Matamoros, et al.
Published: (2022-11-01)

Therapeutic Effects of <i>Morinda citrifolia</i> Linn. (Noni) Aqueous Fruit Extract on the Glucose and Lipid Metabolism in High-Fat/High-Fructose-Fed Swiss Mice
by: Aline Carla Inada, et al.
Published: (2020-11-01)

Variation in the Fatty Acid Synthase Gene (<em>FASN</em>) and Its Association with Milk Traits in Gannan Yaks
by: Bingang Shi, et al.
Published: (2019-08-01)

Metabolic-associated fatty liver disease and lipoprotein metabolism
by: Joerg Heeren, et al.
Published: (2021-08-01)

(−)-Epigallocatechin 3-Gallate Synthetic Analogues Inhibit Fatty Acid Synthase and Show Anticancer Activity in Triple Negative Breast Cancer
by: Joan Crous-Masó, et al.
Published: (2018-05-01)

Thematic review series: Patient-Oriented Research. Recent advances in liver triacylglycerol and fatty acid metabolism using stable isotope labeling techniques
by: Elizabeth J. Parks, et al.
Published: (2006-08-01)

Oncogenic Integration of Nucleotide Metabolism via Fatty Acid Synthase in Non-Hodgkin Lymphoma
by: Dashnamoorthy Ravi, et al.
Published: (2021-10-01)

Fatty Acid Synthase Inhibitor G28 Shows Anticancer Activity in EGFR Tyrosine Kinase Inhibitor Resistant Lung Adenocarcinoma Models
by: Emma Polonio-Alcalá, et al.
Published: (2020-05-01)

Fatty Acid Synthase Mutations Predict Favorable Immune Checkpoint Inhibitor Outcome and Response in Melanoma and Non-Small Cell Lung Cancer Patients
by: Qinghua Wang, et al.
Published: (2022-11-01)

Ovarian Cancer-Intrinsic Fatty Acid Synthase Prevents Anti-tumor Immunity by Disrupting Tumor-Infiltrating Dendritic Cells
by: Li Jiang, et al.
Published: (2018-12-01)

The Pharmacological or Genetic Blockade of Endogenous De Novo Fatty Acid Synthesis Does Not Increase the Uptake of Exogenous Lipids in Ovarian Cancer Cells
by: Thomas W. Grunt, et al.
Published: (2021-04-01)

Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1
by: Dan Wu, et al.
Published: (2022-01-01)

Quantification of menstrual and diurnal periodicities in rates of cholesterol and fat synthesis in humans.
by: D Faix, et al.
Published: (1993-12-01)

Fatty Acid Synthase Correlates With Prognosis-Related Abdominal Adipose Distribution and Metabolic Disorders of Clear Cell Renal Cell Carcinoma
by: Wenhao Xu, et al.
Published: (2021-01-01)

Hyperinsulinaemia: does it tip the balance toward intrahepatic fat accumulation?
by: Leanne Hodson, et al.
Published: (2019-10-01)

Prognostic and clinicopathological significance of fatty acid synthase in breast cancer: A systematic review and meta-analysis
by: Binyan Liu, et al.
Published: (2023-04-01)

Methyl Brevifolincarboxylate Attenuates Free Fatty Acid-Induced Lipid Metabolism and Inflammation in Hepatocytes through AMPK/NF-κB Signaling Pathway
by: Madamanchi Geethangili, et al.
Published: (2021-09-01)

Celastrol Modulates Lipid Synthesis via PI3K/Akt/mTOR Signaling Axis to finalize Cell Death Response in Prostate Cancer Cells
by: Elif Damla Arisan, et al.
Published: (2017-11-01)

Cucurbitacin B ameliorates AKT-driven fatty liver disease in mice by suppressing AKT/mTORC1 and LXRα/SREBP1 lipogenic pathways
by: Chuting Wang, et al.
Published: (2024-02-01)

SREBP Regulation of Lipid Metabolism in Liver Disease, and Therapeutic Strategies
by: Na Li, et al.
Published: (2023-12-01)

Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
by: Seung-Hoi Koo
Published: (2013-09-01)